Annual Report for the Financial Year 2024-25.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zenlabs Ethica Ltd, a WHO-GMP certified pharma firm based in Chandigarh, submitted its 32nd Annual Report for FY24-25. Operating income fell to Rs. 5,142.25 lakh from Rs. 5,856.31 lakh in the previous year, a decline of around 12%. Profit after tax dropped to Rs. 26.92 lakh from Rs. 42.12 lakh, while EPS slipped to Rs. 0.41 from Rs. 0.65. The Board has decided not to recommend any dividend for the year, and Rs. 26.92 lakh was transferred to general reserves. The 32nd AGM is scheduled for September 29, 2025, where Mrs. Himjyoti (Non-Executive Director) will retire by rotation and seek re-appointment. Statutory auditors M/s N Kumar Chhabra & Co. continue in office, with no change in share capital during the year.
The year saw a clear slowdown in both revenue and profits, with no dividend for shareholders, which may weigh on near-term investor sentiment. However, the company remains profitable and operationally stable.